← Eichor
Study identifier: NCT07714525 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Triamcinolone Nanocapsules After Endoscopic Nasal Surgery

Condition: Chronic Rhinosinusitis (CRS) · Nasal Polyps · Postoperative Healing After Endoscopic Nasal Surgery  ·  Sponsor: Deraya University

PhasePhase 2
Planned participants50
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

This randomised, single-masked, parallel-group clinical trial will evaluate the efficacy and safety of a topical triamcinolone acetonide-loaded polymeric nanocapsule formulation for postoperative care following endoscopic nasal surgery. Participants will receive either the investigational triamcinolone acetonide-loaded nanocapsule formulation or standard normal saline nasal irrigation. Postoperative nasal healing, inflammation, patient-reported sinonasal symptoms, postoperative complications, and corticosteroid-related adverse effects will be compared between the two groups.

This description comes directly from the study's public registry record.

Talk to the study team

Sally Mansour Helmy  ·  +20 102 692 0921  ·  aliaa.gamal@deraya.edu.eg

Aliaa Gamal Hussein  ·  +201003041632  ·  aliaa.gamal@deraya.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Deraya university, faculty of pharmacyMinya, Menia Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07714525